NFKappaB-p105/p50 Polyclonal Antibody, 20ul[BT-AP05982] Cell Screening and Imaging Leukocyte immunoglobulin-like receptor subfamily A

Leukocyte immunoglobulin-like receptor subfamily A member 2 is an activating receptor that inhibits dendritic cell differentiation and antigen presentation and suppresses innate immune response

which mediates multiple protein-protein interactions

this protein may selectively affect the signaling process of ILK-mediated glycogen synthase kinase 3 beta (GSK3beta)

6-pentakisphosphate (InsP5) to PP-InsP4 and affect the growth suppressive and apoptotic activities of interferon-beta in some ovarian cancers

BTBD6 (BTB/POZ domain-containing protein 6)

NFKappaB-p105/p50 Polyclonal Antibody, 20ul[BT-AP05982] Cell Screening and Imaging Leukocyte immunoglobulin-like receptor subfamily ANFKB1 encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF kappa B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra and extra cellular stimuli such as cytokines, oxidant free radicals, ultraviolet irradiation, and